Takeda Pharmaceutical Company Limited (TAK)
Filed: 12 Feb 25, 8:06am
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Equillium, Inc. | COM | 29446K106 | 1,368,733 | 1,824,977 | SH | DFND | 1,824,977 | 0 | 0 | ||
| Ovid Therapeutics Inc. | COM | 690469101 | 5,347,500 | 5,750,000 | SH | DFND | 5,750,000 | 0 | 0 | ||
| Ovid Therapeutics Inc. | COM | 690469101 | 1,664,384 | 1,781,996 | SH | SOLE | 1,781,996 | 0 | 0 | ||
| Xilio Therapeutics, Inc. | COM | 98422T100 | 1,416,116 | 1,475,121 | SH | DFND | 1,475,121 | 0 | 0 | ||
| Turnstone Biologics Corp. | COM | 90042W100 | 447,912 | 895,824 | SH | DFND | 895,824 | 0 | 0 | ||
| Shattuck Labs, Inc. | COM | 82024L103 | 623,899 | 515,619 | SH | DFND | 515,619 | 0 | 0 | ||
| Third Harmonic Bio, Inc. | COM | 88427A107 | 379,032 | 36,835 | SH | DFND | 36,835 | 0 | 0 | ||
| Lyell Immunopharma, Inc. | COM | 55083R104 | 526,923 | 823,317 | SH | DFND | 823,317 | 0 | 0 | ||
| Rani Therapeutics Holdings, Inc. | COM | 753018100 | 278,370 | 203,190 | SH | DFND | 203,190 | 0 | 0 | ||
| HilleVax, Inc. | COM | 43157M102 | 13,918,680 | 6,724,000 | SH | DFND | 1 | 6,724,000 | 0 | 0 | |
| STANDARD BIOTOOLS INC. | COM | 34385P108 | 28,901 | 16,515 | SH | DFND | 16,515 | 0 | 0 | ||
| American Well Corp | COM | 03044L204 | 563,564 | 77,733 | SH | DFND | 77,733 | 0 | 0 | ||